BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27910826)

  • 1. Enhancing radiotherapy for lung cancer using immunoadjuvants delivered in situ from new design radiotherapy biomaterials: a preclinical study.
    Hao Y; Yasmin-Karim S; Moreau M; Sinha N; Sajo E; Ngwa W
    Phys Med Biol; 2016 Dec; 61(24):N697-N707. PubMed ID: 27910826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming the Abscopal Effect Using Multifunctional Smart Radiotherapy Biomaterials Loaded with Immunoadjuvants.
    Moreau M; Yasmin-Karim S; Kunjachan S; Sinha N; Gremse F; Kumar R; Chow KF; Ngwa W
    Front Oncol; 2018; 8():56. PubMed ID: 29594038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing Radiotherapeutic Effect With Nanoparticle-Mediated Radiosensitizer Delivery Guided By Focused Gamma Rays In Lewis Lung Carcinoma-Bearing Mouse Brain Tumor Models.
    Lim SH; Li CH; Jeong YI; Jang WY; Choi JM; Jung S
    Int J Nanomedicine; 2019; 14():8861-8874. PubMed ID: 32009784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential for enhancing external beam radiotherapy for lung cancer using high-Z nanoparticles administered via inhalation.
    Hao Y; Altundal Y; Moreau M; Sajo E; Kumar R; Ngwa W
    Phys Med Biol; 2015 Sep; 60(18):7035-43. PubMed ID: 26309064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonistic anti-CD40 antibody therapy is effective against postoperative cancer recurrence and metastasis in a murine tumor model.
    Khong A; Brown MD; Vivian JB; Robinson BW; Currie AJ
    J Immunother; 2013 Sep; 36(7):365-72. PubMed ID: 23924788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiating Antitumor Efficacy Through Radiation and Sustained Intratumoral Delivery of Anti-CD40 and Anti-PDL1.
    Liu HC; Viswanath DI; Pesaresi F; Xu Y; Zhang L; Di Trani N; Paez-Mayorga J; Hernandez N; Wang Y; Erm DR; Ho J; Susnjar A; Liu X; Demaria S; Chen SH; Teh BS; Butler EB; Xuan Chua CY; Grattoni A
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):492-506. PubMed ID: 32768562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brachytherapy attains abscopal effects when combined with immunostimulatory monoclonal antibodies.
    Rodriguez-Ruiz ME; Rodriguez I; Barbes B; Mayorga L; Sanchez-Paulete AR; Ponz-Sarvise M; Pérez-Gracia JL; Melero I
    Brachytherapy; 2017; 16(6):1246-1251. PubMed ID: 28838649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smart Radiation Therapy Biomaterials.
    Ngwa W; Boateng F; Kumar R; Irvine DJ; Formenti S; Ngoma T; Herskind C; Veldwijk MR; Hildenbrand GL; Hausmann M; Wenz F; Hesser J
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):624-637. PubMed ID: 28126309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation and Local Anti-CD40 Generate an Effective
    Yasmin-Karim S; Bruck PT; Moreau M; Kunjachan S; Chen GZ; Kumar R; Grabow S; Dougan SK; Ngwa W
    Front Immunol; 2018; 9():2030. PubMed ID: 30245691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40.
    Khong A; Cleaver AL; Fahmi Alatas M; Wylie BC; Connor T; Fisher SA; Broomfield S; Lesterhuis WJ; Currie AJ; Lake RA; Robinson BW
    BMC Cancer; 2014 Dec; 14():969. PubMed ID: 25518732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of simvastatin on the proliferation, invasion and radiosensitivity in Lewis lung cancer cell line].
    Yu SF; Cheng J; Geng S; Gao S
    Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):245-249. PubMed ID: 28550662
    [No Abstract]   [Full Text] [Related]  

  • 12. CSF-1R-Dependent Lethal Hepatotoxicity When Agonistic CD40 Antibody Is Given before but Not after Chemotherapy.
    Byrne KT; Leisenring NH; Bajor DL; Vonderheide RH
    J Immunol; 2016 Jul; 197(1):179-87. PubMed ID: 27217585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-treatment with Bifidobacterium infantis and its specific antibodies enhance targeted radiosensitization in a murine model for lung cancer.
    Yang J; Wu Z; Chen Y; Hu C; Li D; Chen Y; Imani S; Wen Q; Fu S; Wu J
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):411-422. PubMed ID: 33130941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
    Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
    J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mannatide enhances the efficacy of fractionated and unfractionated radiotherapy in mice bearing Lewis lung cancer].
    Fan RT; Hu Y; Liu JQ; Zhang JJ; Song R; Gu H
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):2072-5. PubMed ID: 22200715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological in situ dose painting for image-guided radiation therapy using drug-loaded implantable devices.
    Cormack RA; Sridhar S; Suh WW; D'Amico AV; Makrigiorgos GM
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):615-23. PubMed ID: 19879699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CD40-induced inflammatory E-cadherin+ dendritic cells enhance T cell responses and antitumour immunity in murine Lewis lung carcinoma.
    Zhang Y; Hu X; Hu Y; Teng K; Zhang K; Zheng Y; Hong X; Yu K; Wang Y; Liu L
    J Exp Clin Cancer Res; 2015 Feb; 34(1):11. PubMed ID: 25651850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle-aided external beam radiotherapy leveraging the Čerenkov effect.
    Ouyang Z; Liu B; Yasmin-Karim S; Sajo E; Ngwa W
    Phys Med; 2016 Jul; 32(7):944-7. PubMed ID: 27397906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of Nanoparticle-Based Radiosensitizers for Radiotherapy Applications.
    Boateng F; Ngwa W
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locally administered TLR7 agonists drive systemic antitumor immune responses that are enhanced by anti-CD40 immunotherapy.
    Broomfield SA; van der Most RG; Prosser AC; Mahendran S; Tovey MG; Smyth MJ; Robinson BW; Currie AJ
    J Immunol; 2009 May; 182(9):5217-24. PubMed ID: 19380767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.